Generate a tailored SOP for Dr. Farida Ahangari. Improve your application with a focused, well-structured draft.
Farida Ahangari is an Assistant Professor in Pulmonary, Critical Care, and Sleep Medicine at Yale School of Medicine. She completed her MD at Iran University of Medical Sciences in Tehran in 1995. Following her medical training, she undertook research training at the Queensland Institute of Medical Research in Australia, focusing on the role of ATM (Ataxia Telangiectasia Mutated protein) in oxidative stress and DNA damage response in cancer. In 2008, Dr. Ahangari joined Yale as a post-doctoral fellow in Professor Jack Elias’s lab, concentrating on animal and cellular models of lung inflammation, asthma, and fibrosis, aiming to study the metabolic links to lung biology. In 2014, she became a faculty member in Professor Naftali Kaminski’s team, where she explores translational aspects of lung diseases and leads various collaborative projects focused on lung development and the transcriptional regulatory models of fibrosis progression. Her main research interest lies in investigating the role of metabolic reprogramming in the pathogenesis of chronic lung diseases, with a focus on developing targeted therapies utilizing microRNA and noncoding RNAs for conditions like idiopathic pulmonary fibrosis (IPF).
GRE is optional for PhD applicants. TOEFL speaking scores below 26 or IELTS speaking below 7.5 may require summer English training.